Anna B. is the Director of Quality- Analytical Molecule Drug Substance Stewardship at Eli Lilly and Company, where they provide GMP stewardship of the analytical control strategy for synthetic peptide drug substances. Previously, Anna served as a Senior Advisor and contributed significantly to regulatory inspection readiness and collaborative analytical strategies. Anna earned a Ph.D. in Chemistry from Penn State University, where they developed methods for identifying exogenous compounds in mammalian cells and published multiple peer-reviewed manuscripts. They also completed a Bachelor's degree in Chemistry at Juniata College, graduating cum laude.
This person is not in any teams
This person is not in any offices